TRAIL
From Proteopedia
(Difference between revisions)
Line 8: | Line 8: | ||
== 3D Structures of TRAIL == | == 3D Structures of TRAIL == | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
+ | |||
TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242 | TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242 | ||
Revision as of 10:23, 7 December 2020
|
3D Structures of TRAIL
Updated on 07-December-2020
TRAIL-R2 domains – extracellular 54-184; transmembrane 208-242
1d0g, 1d4v, 1du3, 5cir - hTRAIL 114-281 + TRAIL-R2 extracellular domain - human
4n90 - hTRAIL 114-281 + hTRAIL-R2 extracellular domain + antibody
1dg6 – hTRAIL jelly-roll domain 91-281
1d2q - hTRAIL 114-281
4i9x – hTRAIL-R2 extracellular domain + UL141
3x3f, 1za3, 4od2, 2h9g, 6t3j – hTRAIL-R2 extracellular domain + antibody
6nhw – hTRAIL-R2 transmembrane domain - NMR
6nhy – hTRAIL-R2 transmembrane domain (mutant) - NMR
References
- ↑ Daniels RA, Turley H, Kimberley FC, Liu XS, Mongkolsapaya J, Ch'En P, Xu XN, Jin BQ, Pezzella F, Screaton GR. Expression of TRAIL and TRAIL receptors in normal and malignant tissues. Cell Res. 2005 Jun;15(6):430-8. PMID:15987601 doi:http://dx.doi.org/10.1038/sj.cr.7290311
- ↑ Dessein PH, Lopez-Mejias R, Ubilla B, Genre F, Corrales A, Hernandez JL, Ferraz-Amaro I, Tsang L, Pina T, Llorca J, Blanco R, Gonzalez-Juanatey C, Gonzalez-Gay MA. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis. Clin Exp Rheumatol. 2015 Jul-Aug;33(4):491-7. Epub 2015 May 11. PMID:25962765